Please provide your email address to receive an email when new articles are posted on . Of 20 hospitals providing insulin algorithms, 60% stated which patients should initiate basal or nutritional ...

The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...

Tandem Diabetes Care has secured a new FDA clearance for its insulin dose-calculating algorithm, opening up its use to adults with Type 2 diabetes. The Control-IQ+ program—now with the added ...

MILPITAS, Calif.--(BUSINESS WIRE)--Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the acquisition of a reinforcement learning ...

Please provide your email address to receive an email when new articles are posted on . The FDA cleared the iLet ACE insulin pump and iLet dosing decision software for people with type 1 diabetes. The ...

A large registry study in young people with type 1 diabetes found that hybrid closed-loop systems were linked to slightly better HbA1c and more time in the target glucose range than open-loop pump ...

Leo, a 22-year-old man who received a diagnosis of type 1 diabetes at 17 years of age, has struggled to meet glucose targets. As a young adult, he has many competing priorities, and diabetes is not ...

Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...

WAN CHAI, WAN CHAI, HONG KONG, January 23, 2026 /EINPresswire.com/ -- Even with the advancement of Automated Insulin ...